Protein 4.1 deficiency and deletion of chromosome 20q are associated with acquired elliptocytosis in myelodysplastic syndrome

Clinical and Laboratory Haematology

Volumn 26, Issue 1, 2004, Pages 69-72

  Hur, M ^a   Lee, K M ^a   Cho, H C ^a   Park, Y I ^a   Kim, S H ^b   Chang, Y W ^c   Kim, Y R ^d   Cho, H I ^d  

^a Hallym University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Korea Cancer Center Hospital   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Elliptocytosis; Myelodysplastic syndrome; Protein 4.1. deletion 20q

Indexed keywords

CELL MEMBRANE PROTEIN; CYTARABINE; ERYTHROCYTE BAND 4.1 PROTEIN; IDARUBICIN;

AGED; ANAMNESIS; ARTICLE; BIOPSY; BLAST CELL; BLOOD; BONE MARROW; CASE REPORT; CELL TRANSFORMATION; CHEMOTHERAPY; CHROMOSOME 20Q; CHROMOSOME DELETION; CLINICAL FEATURE; CYTOGENETICS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HEREDITARY ELLIPTOCYTOSIS; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PHYSICAL EXAMINATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; QUANTITATIVE ANALYSIS; REFRACTORY ANEMIA; REMISSION;

AGED; ANEMIA, REFRACTORY; ANTIBIOTICS, ANTINEOPLASTIC; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 20; CYTARABINE; CYTOSKELETAL PROTEINS; ELLIPTOCYTOSIS, HEREDITARY; ERYTHROCYTES; HUMANS; IDARUBICIN; IMMUNOSUPPRESSIVE AGENTS; MALE; MEMBRANE PROTEINS; MYELODYSPLASTIC SYNDROMES; PANCYTOPENIA;

EID: 1242294601     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0141-9854.2003.00583.x     Document Type: Article

References (19)

1. Aleem A. & Murray J.A. (2001) Spherocytosis prededing the development of myelodysplasia. Clinical and Laboratory Haematology 23, 249-251.
2. Boavida M.G., Ambrósio P., Dhermy D., Silva C. & Correia M.E. Jr (1997) Isochromosme 14q in refractory anemia. Cancer Genetics and Cytogenetics 97, 155-156.
3. Fairbanks G., Steck T.L. & Wallach D.F.H. (1971) Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10, 2606-2617.
4. Fenaux P., Morel P. & Lai J.L. (1996) Cytogenetics of myelodysplastic syndromes. Seminars in Hematology 33, 127-138.
5. Foucar K. (2001) Myelodysplastic syndromes. In: Bone Marrow Pathology. 2nd edn, pp. 226-234, ASCP press, Chicago.
6. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., Sanz M., Vallespi T., Hamblin T., Oscier D., Ohyashiki K., Toyama K., Aul C., Mufti G. & Bennett J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89, 2079-2088.
7. Hartz J.W., Buss D.H., White D.R., Bond M.G. & Scharyj M, (1984) Marked elliptocytosis and schistocytosis in hematopoletic dysplasia. American Journal of Clinical Pathology 82, 354-359.
8. Ideguchi H., Yamada Y., Kondo S., Tamura K., Makino S. & Hamasaki N. (1993) Abnormal erythrocyte band 4.1 protein in myelodysplastic syndrome with elliptocytosis. British Journal of Haematology 85, 387-392.
9. Ishida F., Shimodaira S., Kobayashi H., Saito H., Kaku M., Kanzaki A., Yawata Y., Kitano K. & Kiyosawa K. (1999) Elliptocytosis in myelodysplastic syndrome associated with translocation (1;5)(p10;q10) and deletion of 20q. Cancer Genetics and Cytogenetics 108, 162-165.
10. Knapp R.H., Dewald G.D. & Pierre R.V. (1985) Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. Mayo Clinic Proceedings 60, 507-516.
11. Kurtin P.J., Dewald G.W., Shields D.J. & Hanson C.A. (1996) Hematologic disorders associated with deletions of chromosome 20q. American Journal of Clinical Pathology 106, 680-688.
12. Laemmli U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
13. Lee Y.K., Cho H.I., Park S.S., Lee Y.J., Ra E., Chang Y.H., Hur M., Shin H.Y. & Ahn H.S. (2000) Abnormalities of erythrocyte membrane proteins in Korean patients with hereditary spherocytosis. Journal of Korean Medical Science 15, 284-288.
14. Parker J.E. & Mufti G.J. (1998) Ineffective haematopoiesis and apoptosis in myelodysplastic syndromes. British Journal of Haematology 101, 220-230.
15. Rummens J.L., Verfaillie C., Criel A., Hidajat M., Vanhoof A., Van den Berghe H. & Louwagie A. (1986) Elliptocytosis and schistocytosis in myelodysplasia: report of two cases. Acta Haematologica 75, 174-177.
16. Sole F., Espinet B., Sanz G.F., Cervera J., Calasanz M.J., Luno E., Prieto F., Granada I., Hernandez J.M., Cigudosa J.C., Diez J.L., Bureo E., Marques M.L., Arranz E., Rios R., Martinez Climent J.A., Vallespi T., Florensa L. & Woessner S. (2000) Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica Hematologica. British Journal of Haematology 108, 346-356.
17. Tse W.T. & Lux S.E. (1999) Red blood cell membrane disorders. British Journal of Haematology 104, 2-13.
18. Wattel E., Lai J.L., Hebbar M., Preudhomme C., Grahek D., Morel P., Bauters F. & Fenaux P. (1993) De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features? Leukemia Research 17, 921-926.
19. Yunis J.J., Rydell R.E., Oken M.M., Arnesen M.A., Mayer M.G. & Lobell M. (1986) Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 67, 1721-1730.